$2.1B Healthpeak-Brookfield JV Unlocks $1B in Proceeds at 5.9% Cap Rate
DOC sits 42% above its 52-week low of $15.7.
Summary
Healthpeak sold a 49% stake in an 86-property outpatient medical portfolio to Brookfield for $1.025 billion, valuing the portfolio at $2.1 billion. The 5.9% trailing cap rate and $380 per square foot pricing reflect strong demand for healthcare real estate. Healthpeak retains 51% control and a call right after year seven to buy back Brookfield's interest at a 6.5% net return. The deal provides long-term capital while preserving operational control and future upside. This follows a strong Q1 where Healthpeak raised guidance and completed the Janus Living IPO. The joint venture structure could be replicated across other segments, signaling a new capital recycling strategy.
At the time of this announcement, DOC was trading at $22.35 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $15.9B. The 52-week trading range was $15.70 to $22.62. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.